About Ionian Technologies
Ionian Technologies is a Healthcare company based in San Diego (United States) founded in 2000, and was acquired by Alere in July 2010. It develops point-of-care PCR assays for infectious diseases. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is Ionian Technologies Inc. Its competitors include Karius, Day Zero Diagnostics and OpGen; 3 of its 3 listed competitors have raised funding.
Company details
Ionian Technologies developed point-of-care PCR assays for the detection of infectious diseases. Its proprietary NEAR (Nicking Enzyme Amplification Reaction) technology used isothermal PCR to detect minute amounts of pathogenic DNA or RNA in under ten minutes. NEAR can be used on unprocessed or raw clinical samples, which enables use at the point-of-care. Ionian had an ongoing collaboration with Roche and had received a grant from the Bill and Melinda Gates Foundation to develop low cost POC assays for chlamydia, gonorrhea and tuberculosis. In 2010, Alere acquired the company for an undisclosed sum.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website ionian-tech.com
- Social LinkedIn
- Acquired by Alere (Jul 2010)
- Legal Name Ionian Technologies Inc
Investors in Ionian Technologies
Ionian Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alere.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of small rapid diagnostic devices for infectious diseases | 1991 | alere.com | Waltham, United States |
Investor details for Ionian Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ionian Technologies
2 dated milestones of Ionian Technologies across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Ionian Technologies is founded.
- Exit Acquired by Alere.
Competitors of Ionian Technologies
Ionian Technologies has 3 listed competitors in our database, 3 of them funded. They include Karius, Day Zero Diagnostics and OpGen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers |
Detailed competitors of Ionian Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Ionian Technologies (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ionian Technologies
Ionian Technologies was founded in 2000.
Ionian Technologies is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Ionian Technologies developed point-of-care PCR assays for the detection of infectious diseases. Its proprietary NEAR (Nicking Enzyme Amplification Reaction) technology used isothermal PCR to detect minute amounts of pathogenic DNA or RNA in under ten minutes. NEAR can be used on unprocessed or raw clinical samples, which enables use at the point-of-care. Ionian had an ongoing collaboration with Roche and had received a grant from the Bill and Melinda Gates Foundation to develop low cost POC assays for chlamydia, gonorrhea and tuberculosis. In 2010, Alere acquired the company for an undisclosed sum.
Ionian Technologies's top competitors include Day Zero Diagnostics, Karius and OpGen.
Ionian Technologies has 1 investor. Key investors include Alere.
Ionian Technologies operates through Ionian Technologies Inc.
Yes. Ionian Technologies was acquired by Alere in July 2010.